HopeStage
Back to all studies
CompletedNCT01245348

A Genetic Marker and Medication Response in Schizophrenia and Bipolarity

About this titleRead the official source — NCT01245348
Observational studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Franklin LakesSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2010
Recruitment status
Completed
Enrollment listed in the registry
1,110
Sponsor
Medco Health Solutions, Inc.
Sponsor type
Other organization
Study type
Observational
Intervention type
Genetic
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT01245348
Official title
Show the full official title

Relative Effectiveness of Schizophrenia Therapy (REST) Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Franklin Lakes

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medco Health Solutions, Inc.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies